Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea and Magnesium Pidolate in Hemoglobin SC Disease
NCT00532883Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jan 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydroxyurea and Pidolic acid in hemoglobin SC disease (HbSC) (4 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Distribution of the Density of Hemoglobin SC Red Cells at 2 months. Started Jan 2007; status: terminated.
02
Drugs
hydroxyureaPidolic acid
03
Conditions
hemoglobin SC disease (HbSC)
Beyond the preview
Go deeper on NCT00532883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532883.